product

Product Hub: High sensitivity pyrogen testing with the PyroMAT system: make the move to the next MAT generation

Posted: 18 December 2018 | | No comments yet

Used to detect a broad range of pyrogens in parenteral products including pharmaceuticals, biopharmaceuticals and medical devices, the Monocyte Activation Test (MAT) gives an in vitro alternative to conventional animal testing in accordance with regulatory guidelines.

Merck

With our new Mono-Mac-6 cell line-based MAT, we provide a robust, reliable and standardised method for pyrogen detection.

What can you expect from the PyroMAT system?

  • A pyrogen test that ensures the detection of a broad range of contaminants

The monocyte activation test relies on the human immune reaction to pyrogenic contaminants. Using a source of monocytes, this test mimics the activation of monocytes and measures the release of cytokines to quantify the pyrogenicity of the tested sample.

The rest of this content is restricted - login or subscribe free to access

European Pharmaceutical Review issue 1 2019 coverThank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • bi-monthly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here

 

Send this to a friend